LOG IN
or
SIGN UP
Sign up

ADMA Biologics Company

company logo

ADMA Biologics

Website
https://www.admabiologics.com
Founded
2004
Size
201 to 500 employees
headquarter
Ramsey, NJ
Revenue
$25M to $100M (USD)
Industry
Pharmaceutical & Biotechnology
About ADMA Biologics

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of Primary Immune Deficiency Disease (PIDD) and certain infectious diseases. ADMA's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. ADMA’s lead product candidate, RI-002, has completed a Phase III clinical trial in patients with PIDD and has met the primary endpoint. A BLA for RI-002 was accepted by the FDA on September 18, 2015. The company has received U.S. Patent 9,107,906.

Other Jobs at ADMA Biologics
No jobs found for now, try later
Find another company
Search
free newsletter
Newsletter
Get the latest jobs alerts and articles from us.
Subscribe
OK
Yes
No